184 related articles for article (PubMed ID: 22563022)
1. Does doxycycline protect against development of Clostridium difficile infection?
Doernberg SB; Winston LG; Deck DH; Chambers HF
Clin Infect Dis; 2012 Sep; 55(5):615-20. PubMed ID: 22563022
[TBL] [Abstract][Full Text] [Related]
2. Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia.
O'Leary AL; Chan AK; Wattengel BA; Xu J; Mergenhagen KA
Am J Infect Control; 2024 Mar; 52(3):280-283. PubMed ID: 37921728
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Bateman BT; Rassen JA; Schneeweiss S; Bykov K; Franklin JM; Gagne JJ; Polinski JM; Liu J; Kulik A; Fischer MA; Choudhry NK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):472-8. PubMed ID: 23541855
[TBL] [Abstract][Full Text] [Related]
4. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
Dubberke ER; McMullen KM; Mayfield JL; Reske KA; Georgantopoulos P; Warren DK; Fraser VJ
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):332-7. PubMed ID: 19239377
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.
Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P
World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797
[TBL] [Abstract][Full Text] [Related]
6. The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study.
Brown KA; Fisman DN; Moineddin R; Daneman N
PLoS One; 2014; 9(8):e105454. PubMed ID: 25157757
[TBL] [Abstract][Full Text] [Related]
7. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic-Specific Risk for Community-Acquired
Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
10. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.
Kuntz JL; Chrischilles EA; Pendergast JF; Herwaldt LA; Polgreen PM
BMC Infect Dis; 2011 Jul; 11():194. PubMed ID: 21762504
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection in critically injured trauma patients.
Lumpkins K; Bochicchio GV; Joshi M; Gens R; Bochicchio K; Conway A; Schaub S; Scalea T
Surg Infect (Larchmt); 2008 Oct; 9(5):497-501. PubMed ID: 18687049
[TBL] [Abstract][Full Text] [Related]
12. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.
El Feghaly RE; Stauber JL; Deych E; Gonzalez C; Tarr PI; Haslam DB
Clin Infect Dis; 2013 Jun; 56(12):1713-21. PubMed ID: 23487367
[TBL] [Abstract][Full Text] [Related]
13. Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.
Wombwell E
Microbes Infect; 2023; 25(3):105041. PubMed ID: 36058513
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.
Dubberke ER; Butler AM; Hota B; Khan YM; Mangino JE; Mayer J; Popovich KJ; Stevenson KB; Yokoe DS; McDonald LC; Jernigan J; Fraser VJ;
Infect Control Hosp Epidemiol; 2009 Jun; 30(6):518-25. PubMed ID: 19419269
[TBL] [Abstract][Full Text] [Related]
15. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.
Shen NT; Maw A; Tmanova LL; Pino A; Ancy K; Crawford CV; Simon MS; Evans AT
Gastroenterology; 2017 Jun; 152(8):1889-1900.e9. PubMed ID: 28192108
[TBL] [Abstract][Full Text] [Related]
16. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
Maziade PJ; Andriessen JA; Pereira P; Currie B; Goldstein EJ
Curr Med Res Opin; 2013 Oct; 29(10):1341-7. PubMed ID: 23931498
[TBL] [Abstract][Full Text] [Related]
17. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S
Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554
[TBL] [Abstract][Full Text] [Related]
18. Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed.
Freedberg DE; Salmasian H; Cohen B; Abrams JA; Larson EL
JAMA Intern Med; 2016 Dec; 176(12):1801-1808. PubMed ID: 27723860
[TBL] [Abstract][Full Text] [Related]
19. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
[TBL] [Abstract][Full Text] [Related]
20. Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics.
Kim JS; Ward KK; Shah NR; Saenz CC; McHale MT; Plaxe SC
Support Care Cancer; 2013 Nov; 21(11):3103-7. PubMed ID: 23839499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
